Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 study of trastuzumab with bevacizumab and sequential capecitabine or docetaxel in HER2-positive locally recurrent or metastatic brea…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer [Phase 4]
This document reports the completion of a Phase 4 open-label, multicenter trial evaluating the efficacy and safety of sequential neoadjuvant…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the safety and efficacy of Jobelyn in breast cancer patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice
The clinical trial evaluating nab-paclitaxel (Abraxane) for metastatic breast cancer in routine clinical practice has been terminated.
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)
An observational study update describing outcomes for breast cancer patients with bone metastases who are receiving ibandronate (Bondronat).…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-31FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASLODEX (fulvestrant) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer [NA]
Results from a completed study comparing Positron Emission Mammography to standard mammography in women at high risk for breast cancer have …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing S-1 plus docetaxel versus capecitabine plus docetaxel as first-line therapy for advanced breast cancer.
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors
The document reports on a clinical trial investigating subgroups of breast cancer survivors who have high cardiovascular risk. The status is…
-
FDA approval · 2016-10-28FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for FEMARA (letrozole) from Novartis Pharmaceuticals Corporation. The approval indicates an upda…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer [Phase 2]
A Phase II clinical trial evaluating metronomic capecitabine in combination with oral vinorelbine for metastatic breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial of platinum-based chemoradiation for locally advanced triple-negative breast cancer was terminated, with results…
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
A completed clinical trial evaluating the use of whole-body MRI to detect metastases in breast cancer patients.
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: Pectoral Nerve Blockade in Mastectomy [Phase 4]
Phase 4 clinical trial evaluating pectoral nerve blockade for postoperative pain after mastectomy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation [Phase 2]
A Phase 2 trial completed evaluating sentinel lymph node biopsy after peritumoral injection with blue dye confirmation in breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial evaluating the radiotracer Anti-[18F]FACBC for PET-CT imaging in breast cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Couples Approach to Enhance Breast Cancer Survivorship [NA]
This clinical trial studied a couples-based approach to enhance breast cancer survivorship. The study in early-stage breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Pharmacist's Influence on Breast Cancer Patient Quality of Life [NA]
A completed clinical trial assessed the influence of pharmacists on the quality of life in patients with breast cancer.
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer [EARLY_Phase 1]
This entry describes an early-phase feasibility study using CEST MRI in patients with early-stage breast cancer. The trial is terminated.
-
FDA approval · 2016-10-26FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Faslodex (fulvestrant) submitted by AstraZeneca Pharmaceuticals LP. This notice confirms the…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Impact of COX2 on Sera Biomarkers From Obese Subjects [EARLY_Phase 1]
A Phase 1 clinical trial update investigating the impact of COX-2 on serum biomarkers in obese breast cancer survivors; the study status is …
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women [Phase 3]
A Phase 3 trial evaluating whether omega-3 fatty acids influence risk factors for breast cancer in healthy premenopausal women. The study ha…
-
CLINICAL_TRIALS withdrawal · 2016-10-26Clinical Trial Update: Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab [Phase 1, Phase 2]
The Phase 1/2 trial of trastuzumab in combination with AMG 479 for HER-2 overexpressing metastatic breast cancer progressing on trastuzumab …
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Integrative Approaches for Cancer Survivorship [NA]
This clinical trials update reports that a study from the University of California, San Francisco evaluating integrative approaches for canc…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients
A completed study exploring the relationships between sleep, fatigue, and pain in patients with breast cancer treated with aromatase inhibit…